Reviews
14 March 2014
Vol. 65 No. 6 (2013)
https://doi.org/10.4081/reumatismo.2013.721

Intra-articular therapy with tumor necrosis factor-α antagonists: an update

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
intra-articular therapy, sieronegative spondyloarthritis, anti-TNF agents, refractory monoarthritis.
2542
Views
1204
Downloads

Authors

S. Bello
s.bello1@virgilio.it
Rheumatology Unit, Policlinico Hospital, University of Bari, Italy.
C. Bonali
Rheumatology Unit, Policlinico Hospital, University of Bari, Italy.
L. Serafino
Rheumatology Unit, Policlinico Hospital, University of Bari, .
C. Rotondo
Rheumatology Unit, Policlinico Hospital, University of Bari, .
N. Terlizzi
Rheumatology Unit, Policlinico Hospital, University of Bari, .
G. Lapadula
Rheumatology Unit, Policlinico Hospital, University of Bari, Italy.
The aim of the study was to review from the present literature the intra-articular (IA) use of the TNF-blocking drugs. A total of 28 papers about this topic were found through a search in PubMed; the first publication’s date was July 2003. These studies include a total of 214 patients affected by 12 different joint diseases that reported a total of 1046 intra-articular therapies carried out in 10 different joint sites. Infliximab and etanercept were the most widely used medications. The safety of this treatment clearly emerges from our analysis, while more difficult was the evaluation of its efficacy. Nevertheless we deduced an ideal patient profile that may better respond to the IA anti-TNF treatment.

Altmetrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

none
S. Bello, Rheumatology Unit, Policlinico Hospital, University of Bari
Già borsista,attualmente collaboratore esterno con finalità di ricerca,presso ambulatorio dedicato alle terapie biologiche,

How to Cite



Intra-articular therapy with tumor necrosis factor-α antagonists: an update. (2014). Reumatismo, 65(6), 257-263. https://doi.org/10.4081/reumatismo.2013.721

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.